Corient Private Wealth’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
+63,740
| New | +$215K | ﹤0.01% | 2282 |
|
|
2025
Q1 | – | Sell |
-63,740
| Closed | -$140 | – | 2353 |
|
|
2024
Q4 | $140 | Hold |
63,740
| – | – | ﹤0.01% | 2345 |
|
|
2024
Q3 | $159K | Buy |
63,740
+20,370
| +47% | +$50.7K | ﹤0.01% | 2233 |
|
|
2024
Q2 | $55.5K | Hold |
43,370
| – | – | ﹤0.01% | 2246 |
|
|
2024
Q1 | $125K | Buy |
43,370
+14,000
| +48% | +$40.5K | ﹤0.01% | 2154 |
|
|
2023
Q4 | $216K | Sell |
29,370
-15,284
| -34% | -$112K | ﹤0.01% | 2034 |
|
|
2023
Q3 | $343K | Hold |
44,654
| – | – | ﹤0.01% | 1684 |
|
|
2023
Q2 | $453K | Sell |
44,654
-2,000
| -4% | -$20.3K | ﹤0.01% | 1494 |
|
|
2023
Q1 | $453K | Sell |
46,654
-765
| -2% | -$7.43K | ﹤0.01% | 1417 |
|
|
2022
Q4 | $230K | Buy |
+47,419
| New | +$230K | ﹤0.01% | 1437 |
|